Corrigendum to Intimation dated 06th February, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Titan Biotech Ltd has issued a corrigendum to its earlier intimation dated February 6, 2026, fixing two typographical errors. First, the newspaper 'Naya India' was wrongly tagged as a Marathi publication, when in fact it is a Hindi newspaper. Second, the BSE scrip code was incorrectly mentioned as 530045, whereas the correct scrip code is 524717. The original filing was made under a SEBI circular requiring companies to publish newspaper advertisements informing shareholders about a special window for re-lodgement of share transfer requests and dematerialisation of physical shares. The company clarified that the actual advertisements published on February 6, 2026, and those available on the company's website are correct, and all other details in the original intimation remain unchanged.
This is a purely administrative correction with no material impact on the business, shareholders, or stock price. Investors should note the correct BSE scrip code for Titan Biotech Ltd is 524717.